The Chancellor presented her budget to Parliament on Wednesday 30th October. Here are our initial thoughts on how this Budget ...

Join our advent challenge, and complete 25 miles throughout December. Whether you walk, jog or run, make every mile count this Christmas and raise funds for vital dementia research. Join the Facebook ...

Take on Tough Mudder at Badminton Estate for Alzheimer's Research UK! Push yourself to the limits in this mud-splattered obstacle course challenge —a thrilling test of endurance, teamwork, and grit.

Take on Tough Mudder at Hopetown Estate for Alzheimer's Research UK! Push yourself to the limits in this mud-splattered obstacle course challenge —a thrilling test of endurance, teamwork, and grit.

Take on Tough Mudder at Belvoir Castle for Alzheimer's Research UK! Push yourself to the limits in this mud-splattered obstacle course challenge —a thrilling test of endurance, teamwork, and grit.

Take on your Tough Mudder challenge at Broughton Hall for Alzheimer's Research UK! Push yourself to the limits in this mud-splattered obstacle course challenge —a thrilling test of endurance, teamwork ...

Take on your Tough Mudder challenge at Culden Faw for Alzheimer's Research UK! Push yourself to the limits in this mud-splattered obstacle course challenge —a thrilling test of endurance, teamwork, ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...

Our brains control everything we think, feel, remember and do. There are diseases that stop a person’s brain from working properly. When a person has one of these diseases, they may have problems ...

Thanks to our incredible supporters, 2023/24 was a record-breaking year for Alzheimer’s Research UK. Between 1 April 2023 and 31 March 2024, we achieved a phenomenal £57 million income. Thank you to ...

Our next Research Conference is taking place on Tuesday 25 February and Wednesday 26 February 2025 at ICC Birmingham and online. Our conference provides a fantastic chance to gain insights from ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments. One of these, lecanemab ...